Summary
This prediction ended on 07.09.15 with a price of €117.30. The price of Bayer AG has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.21%. DirectorDealer_Intensive has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | 15.267% | 15.267% | 73.731% | -34.026% |
| iShares Core DAX® | 1.917% | 1.088% | 17.187% | 65.270% |
| iShares Nasdaq 100 | 0.911% | 1.674% | 7.930% | 101.983% |
| iShares Nikkei 225® | 0.833% | -1.712% | 12.100% | 44.368% |
| iShares S&P 500 | 0.242% | 1.258% | 3.167% | 62.336% |
Comments by DirectorDealer_Intensive for this prediction
In the thread Bayer AG diskutieren
Director Dealing: Kauf
Director Dealing / Insider Kauf von Achleitner, Dr. Paul (Aufsichtsorgan)
- Handelstag: 03.03.15
- Volumen: 44995 €
- Meldender: Achleitner, Dr. Paul
Wir werten alle Insider Käufe aus. Gemeinsam mit der Universität Innsbruck wurde eine Handelsstrategie auf Basis des Intensive Tradings entwickelt. Mehr Informationen finden Sie im Profil von DirectorDealer_Intensive
.
(Laufzeit überschritten)